CME Group Inc. (NASDAQ:CME) Receives Average Rating of “Reduce” from Analysts

CME Group Inc. (NASDAQ:CMEGet Free Report) has been given a consensus rating of “Reduce” by the thirteen analysts that are presently covering the stock, Marketbeat Ratings reports. Four investment analysts have rated the stock with a sell rating, six have given a hold rating and three have assigned a buy rating to the company. The average 12 month target price among brokers that have updated their coverage on the stock in the last year is $213.77.

A number of equities analysts recently weighed in on CME shares. TD Cowen assumed coverage on shares of CME Group in a research report on Thursday, September 26th. They set a “hold” rating and a $221.00 target price for the company. Barclays increased their price target on CME Group from $208.00 to $209.00 and gave the company an “equal weight” rating in a research note on Thursday, July 25th. Piper Sandler reaffirmed an “overweight” rating and issued a $225.00 price objective on shares of CME Group in a research note on Tuesday, August 20th. Bank of America raised their target price on shares of CME Group from $177.00 to $180.00 and gave the company an “underperform” rating in a report on Thursday. Finally, Royal Bank of Canada reiterated a “sector perform” rating and set a $235.00 price objective on shares of CME Group in a research report on Thursday.

Read Our Latest Research Report on CME Group

Insider Activity

In other CME Group news, Director Bryan T. Durkin sold 7,593 shares of the business’s stock in a transaction dated Friday, August 30th. The stock was sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the sale, the director now owns 55,607 shares in the company, valued at approximately $11,932,706.13. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, Director Bryan T. Durkin sold 7,593 shares of the company’s stock in a transaction dated Friday, August 30th. The stock was sold at an average price of $214.59, for a total value of $1,629,381.87. Following the sale, the director now owns 55,607 shares in the company, valued at $11,932,706.13. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Lynne Fitzpatrick sold 754 shares of CME Group stock in a transaction that occurred on Sunday, September 15th. The shares were sold at an average price of $216.99, for a total value of $163,610.46. Following the transaction, the chief financial officer now owns 13,261 shares of the company’s stock, valued at approximately $2,877,504.39. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 0.30% of the company’s stock.

Institutional Investors Weigh In On CME Group

A number of large investors have recently modified their holdings of CME. Vanguard Group Inc. increased its holdings in shares of CME Group by 0.6% during the 4th quarter. Vanguard Group Inc. now owns 33,451,194 shares of the financial services provider’s stock worth $7,044,821,000 after buying an additional 215,044 shares during the last quarter. Capital International Investors increased its position in shares of CME Group by 24.1% during the 1st quarter. Capital International Investors now owns 15,809,175 shares of the financial services provider’s stock worth $3,403,557,000 after purchasing an additional 3,069,806 shares during the last quarter. Ameriprise Financial Inc. raised its holdings in CME Group by 11.3% in the 2nd quarter. Ameriprise Financial Inc. now owns 5,283,196 shares of the financial services provider’s stock valued at $1,038,676,000 after buying an additional 537,758 shares during the period. FIL Ltd lifted its position in CME Group by 0.7% in the fourth quarter. FIL Ltd now owns 4,269,327 shares of the financial services provider’s stock valued at $899,120,000 after buying an additional 29,398 shares during the last quarter. Finally, GUARDCAP ASSET MANAGEMENT Ltd boosted its stake in CME Group by 1.1% during the first quarter. GUARDCAP ASSET MANAGEMENT Ltd now owns 4,009,068 shares of the financial services provider’s stock worth $863,112,000 after buying an additional 43,293 shares during the period. Hedge funds and other institutional investors own 87.75% of the company’s stock.

CME Group Stock Up 0.1 %

CME stock opened at $224.43 on Friday. The business’s 50-day moving average price is $212.17 and its 200-day moving average price is $207.69. The stock has a market cap of $80.81 billion, a P/E ratio of 25.53, a PEG ratio of 8.74 and a beta of 0.55. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.10. CME Group has a twelve month low of $190.70 and a twelve month high of $226.78.

CME Group (NASDAQ:CMEGet Free Report) last announced its quarterly earnings data on Wednesday, July 24th. The financial services provider reported $2.56 EPS for the quarter, beating the consensus estimate of $2.53 by $0.03. CME Group had a net margin of 56.98% and a return on equity of 12.82%. The firm had revenue of $1.53 billion for the quarter, compared to the consensus estimate of $1.53 billion. During the same period last year, the firm earned $2.30 EPS. The company’s revenue was up 12.7% on a year-over-year basis. On average, equities research analysts forecast that CME Group will post 9.94 EPS for the current year.

CME Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, September 25th. Investors of record on Monday, September 9th were given a dividend of $1.15 per share. This represents a $4.60 dividend on an annualized basis and a yield of 2.05%. The ex-dividend date was Monday, September 9th. CME Group’s payout ratio is currently 52.33%.

CME Group Company Profile

(Get Free Report

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Featured Articles

Analyst Recommendations for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.